Physician profile
Robert A Darling
NPI 1588924104
$3,877.12
in general payments reported to CMS, 2019-2025
15 companies · $2,119 in 2025
The $2,119 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.87 · 2020: $121 · 2021: $158 · 2022: $136 · 2023: $490 · 2024: $833 · 2025: $2,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,160 · Travel and Lodging: $876 · Consulting Fee: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,159.60 |
| Travel and Lodging | $875.55 |
| Consulting Fee | $406.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,264.03 | 2023-2025 | Nuvent, Stealthstation S8 Platform, Propel |
| Aerin Medical INC. | $1,232.81 | 2022-2025 | |
| Inspire Medical Systems, INC. | $618.11 | 2023-2025 | Inspire |
| Intersect Ent, INC. | $158.30 | 2021 | |
| Stryker Corporation | $148.10 | 2025 | Scopis Ent |
| Genzyme Corporation | $121.86 | 2025 | |
| Zimmer Biomet Holdings, INC. | $103.77 | 2020 | |
| Optinose US, INC. | $57.25 | 2025 | |
| Medtronic USA, INC. | $36.85 | 2019-2020 | |
| Itamar Medical INC | $31.01 | 2025 | Watchpatone |
| Phathom Pharmaceuticals, INC. | $28.68 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $25.21 | 2023 | Belsomra |
| Xeris Pharmaceuticals, INC. | $18.26 | 2023 | Gvoke Hypopen |
| Regeneron Healthcare Solutions, INC. | $17.57 | 2025 | Dupixent |
| Hikma Pharmaceuticals USA | $15.31 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Darling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.